洛阳钼业（603993.SH） 持续成长的国际铜钴龙头 有色金属 推荐（首次） 4 月 24 日：7.06 元 主要数据 | 行业 | 有色金属 | | --- | --- | | 公司网址 | www.cmoc.com | | 大股东/持股 | 鸿商产业控股集团有限公司/ | | | 24.69% | | 实际控制人 | 于泳 | | 总股本(百万股) | 21499 | | 流通 A 股(百万股) | 17566 | | 流通 B/H 股(百万股) | 3933 | | 总市值（亿元） | 1456 | | 流通 A 股市值(亿元) | 1240 | | 每股净资产(元) | 3.24 | | 资产负债率(%) | 49.52 | 行情走势图 -30% -20% -10% 0% 10% 20% 30% 2024/4 2024/6 2024/8 2024/10 2024/12 2025/2 2025/4 洛阳钼业 沪深300 证券分析师 平安观点： | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- ...

Investment Rating - The report maintains a "Recommendation" rating for the company [6][14]. Core Insights - The company reported a strong Q1 performance with revenue of 800 million yuan, an increase of 18.21%, and a narrowed net loss of 4.2842 million yuan, improving by 95.48% [4]. - The core driver for Q1 was the overseas and small molecule CDMO business, with overseas revenue reaching 609 million yuan, up approximately 30%, while domestic revenue decreased by about 8% to 192 million yuan [5]. - The small molecule CDMO business generated 761 million yuan in revenue, reflecting a growth of around 20% [5]. - The overall gross margin for Q1 was 26.33%, an increase of 10.49 percentage points, attributed to improved capacity utilization [6]. - The company expects continued improvement in profitability, with projected net profits for 2025-2027 at 290 million, 2.46 billion, and 5.15 billion yuan respectively [6]. Summary by Sections Financial Performance - Q1 revenue was 800 million yuan, with a year-on-year growth of 18.21% [4]. - The net loss for Q1 was 4.2842 million yuan, a significant improvement of 95.48% [4]. - The gross margin for Q1 was 26.33%, up by 10.49 percentage points [6]. Business Segments - Overseas revenue was 609 million yuan, increasing by approximately 30% [5]. - Domestic revenue was 192 million yuan, down by about 8% [5]. - The small molecule CDMO segment achieved 761 million yuan in revenue, growing by around 20% [5]. Future Projections - The company forecasts net profits of 290 million yuan in 2025, 2.46 billion yuan in 2026, and 5.15 billion yuan in 2027 [6].

Investment Rating - The investment rating for the company is "Recommended (Maintain)" with a current price of 24.74 CNY [1] Core Views - The company has significantly increased its profits due to the upward cycle of refrigerants, with a 2024 revenue of 24.462 billion CNY, an 18.43% year-on-year increase, and a net profit of 1.960 billion CNY, a 107.69% increase year-on-year [3][4] - The supply-demand structure of fluorinated refrigerants has improved, leading to sustained price increases, which is a major driver of the company's profit growth [4][9] Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 24.462 billion CNY, up 18.43% year-on-year, and a net profit of 1.960 billion CNY, up 107.69% year-on-year [3][4] - The profit distribution plan for 2024 includes a cash dividend of 2.3 CNY per 10 shares (tax included) [3] Business Segments - The fluorochemical raw materials segment saw a production increase of 6.22% year-on-year, while external sales decreased by 4.59%. The average monthly sales price increased by 23.19%, leading to a total revenue increase of 17.54% [4] - The refrigerant segment experienced a production and sales volume increase of 21.12% and 22.61% respectively, with a revenue of 9.447 billion CNY, a 62.69% increase year-on-year [5] - The fluorinated fine chemicals segment saw a dramatic increase in production and sales volume by 148.99% and 254.95% respectively, with a revenue increase of 99.48% [6] Market Outlook - The company holds the largest production quotas for HCFC-22 and HFCs in the country, with 3.89 million tons and 299,800 tons respectively, which is 26.10% and 39.6% of the national total [4] - The refrigerant industry is expected to continue benefiting from strong domestic demand in air conditioning and automotive sectors, supported by government subsidies [9] Future Projections - The company is projected to achieve a net profit of 2.764 billion CNY in 2025, 3.323 billion CNY in 2026, and 3.815 billion CNY in 2027, with corresponding P/E ratios of 24.2, 20.1, and 17.5 [7][9]

医药 公 司 报 告 爱尔眼科(300015.SZ) 相关研究报告 【平安证券】爱尔眼科（300015.SZ）*季报点评*具 备经营韧性，静待消费复苏*推荐20241101 证券分析师 叶寅 投资咨询资格编号 S1060514100001 BOT335 事项： 具备经营韧性，25Q1业绩快速增长 推荐 ( 维持) 股价:12.72元 行情走势图 请通过合法途径获取本公司研究报告，如经由未经许可的渠道获得研究报告，请慎重使用并注意阅读研究报告尾页的声明内容 2025年04月25日 公司发布2024年年报以及2025年一季报，2024年收入实现209.83亿元，同比 增长3.02%，归母净利润实现35.56亿元，同比增长5.87%，扣非归母净利润 实现30.99亿元，同比-11.82%。2025Q1公司收入实现60.26亿元，同比增长 15.97%，归母净利润实现10.50亿元，同比增长16.71%，扣非归母净利润实 现10.60亿元，同比增长25.78%。公司拟向全体股东每 10 股派发现金红利 1.6 元（含税）。 平安观点： 研 究 报 告 YEYIN757@pingan.com.cn 倪亦道 投资咨询资格 ...

公 司 报 告 医药 2025年04月25日 博腾股份(300363.SZ) Q1表现理想，小分子业务实现扭亏 推荐 ( 维持) 股价:14.78元 主要数据 | 行业 | 医药 | | --- | --- | | 公司网址 | www.portonpharma.com | | 大股东/持股 | 重庆两江新区产业发展集团有限公 | | | 司/14.48% | | 实际控制人 | 居年丰,陶荣,张和兵 | | 总股本(百万股) | 545 | | 流通A股(百万股) | 500 | | 流通B/H股(百万股) | | | 总市值(亿元) | 81 | | 流通A股市值(亿元) | 74 | | 每股净资产(元) | 9.56 | | 资产负债率(%) | 37.5 | 行情走势图 相关研究报告 【平安证券】博腾股份（300363.SZ）*年报点评*经 营否极泰来，有望年内实现扭亏*推荐20250331 证券分析师 事项： 公司发布25年一季报，实现营收8.01亿元（+18.21%），实现归母净利 润 -428.42 万 元 （ +95.48% ） ， 扣 非 后 归 母 净 利 润 -1009.01 万 元 ...

Investment Rating - The investment rating for the company is "Recommended (Maintain)" [1] Core Views - The company has significantly increased its profits due to the upward cycle of refrigerants, with a revenue of 24.462 billion yuan in 2024, representing an 18.43% year-on-year increase, and a net profit of 1.960 billion yuan, which is a 107.69% increase year-on-year [4][5] - The supply-demand structure of fluorinated refrigerants has improved, leading to a continuous rise in prices, which has driven the company's high growth in performance [5][9] Summary by Relevant Sections Financial Performance - In 2024, the company achieved a revenue of 24.462 billion yuan, up 18.43% year-on-year, and a net profit of 1.960 billion yuan, up 107.69% year-on-year [4][5] - The company plans to distribute a cash dividend of 2.3 yuan per 10 shares (including tax) [4] Business Segments - The production of fluorinated chemical raw materials increased by 6.22% year-on-year, while external sales decreased by 4.59%. The average monthly sales price increased by 23.19%, leading to a total revenue increase of 17.54% [5] - The production and sales volume of fluorinated refrigerants increased by 21.12% and 22.61% respectively, with a revenue of 9.447 billion yuan, a 62.69% increase year-on-year [6] - The production and sales of fluorinated fine chemicals saw a significant increase of 148.99% and 254.95% respectively, with a revenue increase of 99.48% [7] Market Outlook - The refrigerant market is expected to continue its upward trend due to supply constraints and strong demand from downstream industries such as air conditioning and automotive [9] - The company holds the largest production quotas for HCFC-22 and HFCs in the country, which strengthens its market position [5][9] Future Projections - The company forecasts a net profit of 2.764 billion yuan in 2025, 3.323 billion yuan in 2026, and 3.815 billion yuan in 2027, reflecting strong growth potential [9]

Investment Rating - The report maintains a "Recommendation" rating for the company [3][6] Core Views - The company demonstrated operational resilience with a rapid growth in performance in Q1 2025, driven by consumer-oriented projects [6] - The 2024 revenue reached 20.983 billion yuan, a year-on-year increase of 3.02%, while the net profit attributable to shareholders was 3.556 billion yuan, up 5.87% year-on-year [3][6] - The report anticipates continued recovery in performance, supported by stable pricing in refractive surgery and an increase in the proportion of high-end procedures [6] Financial Summary - For 2024, the company expects revenue of 20.983 billion yuan, with a projected growth of 15.3% in 2025, reaching 24.199 billion yuan [6][9] - The net profit for 2024 is projected at 4.139 billion yuan, with a growth rate of 16.4% in 2025 [6][9] - The gross margin for the medical services segment is expected to be 48.1% in 2024, slightly declining from previous years [6][9] - The company plans to distribute a cash dividend of 1.6 yuan per 10 shares to all shareholders [3][6] Performance Metrics - The report outlines key performance metrics, including an expected EPS of 0.38 yuan for 2024, increasing to 0.44 yuan in 2025 [6][9] - The projected return on equity (ROE) is 17.2% for 2024, with a gradual increase to 18.5% by 2027 [6][9] - The company's asset-liability ratio is forecasted to decrease from 34.4% in 2024 to 22.5% in 2027, indicating improved financial stability [9]

Investment Rating - The investment rating for the company is "Recommended" [4][14]. Core Views - The company has optimized its revenue structure and improved profitability, with a slight decrease in revenue for 2024 but significant growth in net profit [4][7]. - The company plans to distribute cash dividends and increase share capital through bonus shares [4]. - The company is focusing on expanding its overseas market presence, particularly in Europe, India, and the Middle East, while maintaining a strong position in the domestic market [10]. Financial Performance Summary - In 2024, the company achieved operating revenue of 4.773 billion yuan, a decrease of 3.2% year-on-year, while net profit attributable to shareholders increased by 46.5% to 419 million yuan [4][6]. - For Q1 2025, the company reported operating revenue of 831 million yuan, a year-on-year increase of 16.8%, and net profit of 88 million yuan, up 71.6% [4][7]. - The gross profit margin for 2024 was 22.9%, an increase of 5.79 percentage points from the previous year, with a net profit margin of 8.73% [7][12]. Revenue Breakdown - In 2024, revenue from photovoltaic inverters was 2.750 billion yuan, a decrease of 4.5%, while revenue from energy storage systems increased slightly to 1.928 billion yuan, a growth of 0.1% [7][10]. - The company’s revenue from overseas markets grew significantly by 68.7% to 1.164 billion yuan, accounting for 24.4% of total revenue [7][10]. Market Position - The company ranks fourth in the domestic photovoltaic inverter bidding market with a total winning capacity of 18.2 GW in 2024 [10]. - It is also ranked second in both domestic and overseas markets for energy storage inverters [10]. Future Projections - The company forecasts operating revenues of 6.066 billion yuan in 2025, with a projected net profit of 632 million yuan, reflecting a growth rate of 50.8% [6][12]. - The expected earnings per share (EPS) for 2025 is 1.76 yuan, with a price-to-earnings (P/E) ratio of 16.1 [12].

Investment Rating - The investment rating for the company is "Recommended" [4][13]. Core Views - The company reported a revenue of 9.19 billion yuan in 2024, a year-on-year increase of 1.4%, but the net profit attributable to shareholders decreased by 15.1% to 590 million yuan due to increased impairment losses [4][7]. - In Q1 2025, the company achieved a revenue of 1.27 billion yuan, a year-on-year decline of 14.3%, while the net profit attributable to shareholders increased by 14.2% to 100 million yuan [4][7]. - The company plans to distribute a cash dividend of 3.2 yuan per 10 shares (tax included) for 2024 [4]. Summary by Sections Financial Performance - In 2024, the company experienced a revenue of 91.9 billion yuan, with a gross margin of 18.1%, slightly down by 0.3 percentage points [7]. - The net profit for 2024 was 5.9 billion yuan, reflecting a significant decline due to increased impairment losses totaling 430 million yuan [7][9]. - The company’s revenue is projected to grow to 99.3 billion yuan in 2025, with a net profit of 7.5 billion yuan expected for 2025 [10][11]. Business Segments - The decorative materials segment generated 74.0 billion yuan in revenue, up 7.99% year-on-year, with a gross margin of 17.04% [7]. - The custom home segment reported a revenue of 17.2 billion yuan, down 18.73%, primarily due to challenges in the engineering business [7]. - The company has significantly expanded its rural store network, with 1,413 new stores established, bringing the total to 5,522 [7]. Cash Flow and Financial Ratios - The net cash flow from operating activities for 2024 was 1.15 billion yuan, down from 1.91 billion yuan in the previous year [9][12]. - The company’s total assets are projected to reach 6.37 billion yuan in 2025, with a debt-to-asset ratio of 46.1% [10][11]. - The return on equity (ROE) is expected to be 22.7% in 2025, indicating strong profitability [11]. Market Outlook - The domestic engineered wood market is expected to grow, supported by the demand for home renovations [9]. - The company has established strong brand barriers and is focusing on channel transformation, particularly in rural markets [9].

Investment Rating - The report maintains a "Recommended" investment rating for the company [4][12]. Core Insights - The company achieved a revenue of 4.773 billion yuan in 2024, a decrease of 3.2% year-on-year, while the net profit attributable to shareholders increased by 46.5% to 419 million yuan [4][7]. - In Q1 2025, the company reported a revenue of 831 million yuan, reflecting a year-on-year growth of 16.8% [4][7]. - The company plans to distribute a cash dividend of 1.2 yuan per 10 shares and a capital reserve conversion of 4 shares for every 10 shares held [4]. Revenue and Profitability - The company's revenue structure is optimizing, with a notable shift towards overseas markets, where revenue grew by 68.7% to 1.164 billion yuan in 2024, accounting for 24.4% of total revenue [7][8]. - The gross margin improved to 22.9% in 2024, up from 19.2% in 2023, with the net margin also increasing to 8.73% [7][10]. - The company is expected to see continued growth in net profit, with projections of 632 million yuan in 2025 and 1.083 billion yuan in 2027 [6][10]. Market Position and Strategy - The company holds a leading position in the photovoltaic and energy storage inverter markets, ranking fourth globally in photovoltaic inverter shipments in 2023 [8]. - The company is expanding its presence in key overseas markets, including Europe, India, and the Middle East, to mitigate risks associated with domestic policy fluctuations [8][10]. - The focus for 2025 includes advancing large-scale energy storage markets and enhancing supply chain and after-sales service networks in emerging markets along the Belt and Road Initiative [8]. Financial Projections - Revenue is projected to grow to 6.066 billion yuan in 2025, with a compound annual growth rate (CAGR) of 27.1% from 2024 to 2025 [6][10]. - The earnings per share (EPS) are expected to increase from 1.16 yuan in 2024 to 1.76 yuan in 2025, and further to 3.01 yuan by 2027 [6][10]. - The company's price-to-earnings (P/E) ratio is projected to decrease from 24.2 in 2024 to 9.4 by 2027, indicating potential undervaluation [10].